|
Sign In to gain access to subscriptions and/or personal tools.
|
Predictors of Long-Term Major Adverse Cardiac Events and Clinical Restenosis Following Elective Percutaneous Coronary Stenting
Qiangjun Cai*,
Kimberly Skelding,
Arthur Armstrong Jr.,
Dipan Desai,
G. Craig Wood,
and
James Blankenship
* To whom correspondence should be addressed. E-mail: qiangjuncai{at}hotmail.com.
 |
Abstract |
|---|
Limited data exist regarding the predictors of long-term clinical outcomes following elective percutaneous coronary intervention (PCI) in the current era of stenting. The authors investigated the predictors of major adverse cardiac events (MACE) and clinical restenosis in 740 consecutive patients who underwent successful elective PCI with bare metal stents (BMSs) or drug-eluting stents (DESs). At 30-month follow-up, compared with BMS recipients, DES recipients had a significantly lower rate of MACE, which was mainly driven by a decreased repeat target vessel PCI. The rate of 30-month clinical restenosis was significantly lower in DES recipients. The authors conclude that baseline clinical, angiographic, and procedural characteristics determine long-term MACE and clinical restenosis after elective PCI, with DES being the independent predictor for both.
First published on September 25, 2008, doi:10.1177/0003319708321587
Angiology 2009;60:141.
A more recent version of this article appeared on April 1, 2009

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|